Neuropharmacology

Health

A new therapeutic avenue for treating insomnia

Insomnia is one of the major sleep problems with an estimated prevalence of 10 percent to 15 percent in the general population and 30 percent to 60 percent in the older population. Moreover, insomnia frequently co-occurs ...

Neuroscience

Researchers uncover new target of alcohol in the brain

When alcohol enters the brain, it causes neurons in a specialized region called the ventral tegmental area, or VTA—also known as the "pleasure center"—to release dopamine, a neurotransmitter that produces those feel-good ...

Medications

Reclassification recommendations for drug in 'magic mushrooms'

In an evaluation of the safety and abuse research on the drug in hallucinogenic mushrooms, Johns Hopkins researchers suggest that if it clears phase III clinical trials, psilocybin should be re-categorized from a schedule ...

page 2 from 5